Document Detail

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Central Nerve System Metastases from Non-Small Cell Lung Cancer.
MedLine Citation:
PMID:  24861428     Owner:  NLM     Status:  Publisher    
Brain metastases (BM) are common and disastrous occurrence in patients with non-small cell lung cancer (NSCLC). Currently increasing studies suggest remarkable efficacy and mild toxicity of the epidermal growth factor tyrosine kinase inhibitor (EGFR TKI) in these patients, making targeted therapy an attractive option to BM from NSCLC. We here present a review about the use of EGFR-TKIs in this context and the following questions would be discussed: Are TKIs capable of permeating across brain-blood barrier (BBB)? How to boost exposure of EGFR TKI in cerebrospinal fluid to overcome the resistance of refractory metastases? Would the combination with other treatment like radiotherapy bring about advanced effect? And which patients with BM is the fittest population to EGFR-TKI treatment? In fact, though the administration of EGFR TKI only could achieve certain effect with limited penetration across BBB, increasing dose and combined radiotherapy would carry out better outcome. Unsurprisingly EGFR mutations were still the most important predictor of the sensitivity.
Jingze Zhang; Jinming Yu; Xindong Sun; Xue Meng
Related Documents :
21204748 - The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer ...
24331148 - Current readings: the most influential and recent studies regarding resection of lung c...
7141928 - Planned preoperative radiation therapy for advanced laryngeal carcinoma.
24861428 - Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central...
11395228 - Radiation dose response in patients with favorable localized prostate cancer (stage t1-...
2358848 - Intra-arterial bcnu in the treatment of recurrent medulloblastoma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-5-23
Journal Detail:
Title:  Cancer letters     Volume:  -     ISSN:  1872-7980     ISO Abbreviation:  Cancer Lett.     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-5-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  No interaction between tau and TDP-43 pathologies in either Frontotemporal Lobar Degeneration or Mot...
Next Document:  Angiotensin-(1-7) Prevent Atrial Tachycardia Induced Sodium Channel Remodeling.